Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 10, 2010, Pages 1799-1804

  Landry, Daniel L ^a,b   Braden, Gregory L ^a,b,c   Gobeille, Stephen L ^c   Haessler, Sarah D ^a,b   Vaidya, Chirag K ^a,b   Sweet, Stephen J ^a,b,c  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Western New England Renal and Transplant Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; HEPARIN;

ADULT; ARTICLE; BACTEREMIA; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENDOCARDITIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; SEPTIC SHOCK;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; EQUIPMENT DESIGN; FEMALE; GENTAMICINS; HEPARIN; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; PROGRAM EVALUATION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958590280     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01270210     Document Type: Article

References (39)

1. Centers for Medicare and Medicaid Services: 2004 Annual report: End-stage renal disease clinical performance measures project. Am J Kidney Dis 46: 1-100, 2005
2. Vascular Access Working Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S248-S273, 2006
3. Allon M: Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 44: 779-791, 2004 (Pubitemid 39445909)
4. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ: Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study. J Am Soc Nephrol 14: 1863-1870, 2003
5. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled haemodialysis catheter-related infections using catheter-restricted gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 12: 2133-2139, 2002 (Pubitemid 34790791)
6. McIntyre CW, Hulme LJ, Taal M, Fluck RJ: Locking of tunneled haemodialysis catheters with gentamicin and heparin. Kidney Int 66: 801-805, 2004 (Pubitemid 38986971)
7. Betjes MG, van Agteren M: Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19: 1546-1551, 2004
8. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ: A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary haemodialysis access. Infect Control Hosp Epidemiol 26: 520-524, 2005 (Pubitemid 40896141)
9. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE: Randomised, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in haemodialysis patients. J Am Soc Nephrol 16: 2769-2777, 2005
10. Saxena AK, Panhotra BR: The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary haemodialysis catheters: A case controlled study. J Nephrol 18: 755-763, 2005
11. Nori US, Manoharan A, Yee J, Besarab A: Comparison of low-dose gentamicin with minocycline as catéter lock solutions in the prevention of catre-related bacteraemia. Am J Kidney Dis 48: 596-605, 2006 (Pubitemid 44402837)
12. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed haemodialysis catheter- related bacteraemia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int 69: 161-164, 2006
13. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, Abu-Oun BA, Hussain SM, Al-Ghamdi AA: Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70: 1629-1635, 2006 (Pubitemid 44606999)
14. Al-Hwiesh AK, Abdul-Rahman ISA: Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamicin. Saudi J Kidney Dis Transplant 18: 239-247, 2007
15. Zhang P, Yuan J, Tan H, Lv R, Chen J: Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock solution method. Blood Purif 27: 206-211, 2009
16. Cooper RI, Saad TF: Prevention of bacteremia in patients with tunneled cuffed 'permanent' hemodialysis catheters using gentamicin catheter packing. J Am Soc Nephrol 10: 203A, 1999
17. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, Abreo K: Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 3: 108-113, 2002 (Pubitemid 35189921)
18. Duncan N, Singh S, Amao M: A single centre randomized control trial of sodium citrate versus heparin line locks for cuffed central venous cathets. J Am Soc Nephrol 16: 451A, 2005
19. Hendricks L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y: A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 24: 208-211, 2001 (Pubitemid 32479378)
20. Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Van der Merwe WM, Marshall MR: Effect of anti-microbial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: A quality improvement report. Am J Kidney Dis 53: 492-502, 2009
21. Labriola L, Crott R, Jadoul M: Preventing haemodialysis catheter-related bacteraemia with an anti-microbial lock solution: A meta-analysis of prospective randomized trials. Nephrol Dial Tranplant 23: 1666-1672, 2007 (Pubitemid 351767750)
22. Jaffer Y, Selby N, Taal M, Fluck R, McIntyre CW: A meta-analysis of haemodialysis catheter locking solutions in the prevention of catheter related infection. Am J Kidney Dis 51: 233-241, 2008
23. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M: Anti-microbial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47: 83-93, 2008 (Pubitemid 351920592)
24. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR: Meta-analysis: Antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 148: 596-605, 2008 (Pubitemid 351669133)
25. Rabindranath KS, Bansal T, Adams J, Das R, Shail R, Macleod AM, Moore C, Besarab A: Systematic review of anti-microbials for the prevention of haemodialysis catheter- related infections. Nephrol Dial Transplant 24: 3763-3774, 2009
26. Fresenius Medical Care North America: Hemodialysis Procedure Manual. Central Venous Catheter Training Manual: Initiating Treatment Using a Catheter (#132-020-265), Waltham, MA, Fresenius, 2004
27. Fresenius Medical Care North America: Hemodialysis Procedure Manual. Central Venous Catheter Training Manual Part I: Disinfection of Connection Ports of Catheter (#136-020-130), Waltham, MA, Fresenius, 2004
28. Fresenius Medical Care North America: Hemodialysis Procedure Manual. Central Venous Catheter Training Manual Part II: Catheter Care (#136-020-245), Waltham, MA, Fresenius, 2004
29. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A: The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771-1776, 1999 (Pubitemid 29235221)
30. Allon M: Treatment guidelines for dialysis catheter-related bacteremia: An update. Am J Kidney Dis 54: 13-17, 2009
31. Guerraoiu AA, Dacosta EE, Roche BB, Plaidy AA, Laroussinie GG, Didier DA, Deteix PP: Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters. Prospective study, 1999-2003. J Am Soc Nephrol 15: 368A, 2004 (Abstract)
32. Geron R, Tanchilevsky O, Kristal B: Catheter lock solution: Taurolock for the prevention of catheter-related bacteremia in hemodialysis patients. Harefuah 145: 881-884, 2006
33. Taylor C, Cahill J, Gerrish M, Little J: A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. J Renal Care 34: 116-120, 2008
34. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D: Sodium citrate versus heparin catheter locks for cuffed central venous catheters: A single-center randomized controlled trial. Am J Kidney Dis 53: 1034-1041, 2009
35. Vendito M, Tezenas du Montcel S, Robert J, Trystam D, Dighiero J, Hue D, Bessette C, Deray G, Mercadal L: Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: Heparin versus citrate 46% versus heparin/gentamicin. Blood Purif 29: 268-273, 2010
36. Ash SR: The evolution and function of central venous catheters for dialysis. Semin Dial 14: 416-424, 2001 (Pubitemid 33720885)
37. Crnich CJ, Halfmann JA, Crone WC, Maki DG: The effects of prolonged ethanol exposure on the mechanical properties on polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 26: 708-714, 2005
38. Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK: Microbial inactivation properties of a new anti-microbial/ antithrombotic lock solution (citrate/methylene blue/ parabens). Nephrol Dial Transplant 24: 1937-1945, 2009
39. Ash SR, Maki DG, Lavin PT, Winger RK: A multicenter randomized trial of an anti-microbial and antithrombotic lock solution for hemodialysis catheters. J Am Soc Nephrol 20: 69-70A, 2009